ERBB2 and breast carcinoma: Finally, we did not have sufficient sample size to examine this relationship by molecular subtype of breast cancer, so findings may only be generalizable to women with the more common estrogen receptor positive, human epidermal growth factor receptor 2 (HER2) negative, breast cancer.